Baneu Petru, Prelipcean Andreea, Buda Valentina Oana, Jianu Narcisa, Tudor Anca, Andor Minodora, Merlan Cristina, Romanescu Mirabela, Suciu Maria, Buda Simona, Mateoc Teodora, Gurgus Daniela, Dehelean Liana
Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 2 Eftimie Murgu Street, 300041 Timisoara, Romania.
Faculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy, 2 Eftimie Murgu Street, 300041 Timisoara, Romania.
J Clin Med. 2024 Oct 8;13(19):5970. doi: 10.3390/jcm13195970.
: Numerous European countries, including Romania, are facing the concern of rapid ageing of their populations. Moreover, Romania's life expectancy ranks among the lowest in the European Union. In light of this, it is imperative that the assessment of medication-related harm be given national priority in order to secure and enhance pharmacotherapy and the medical act. In this study, we sought to describe and evaluate the under-prescribing practices among the Romanian elderly population. : We conducted a cross-sectional study in urban areas of two counties in Western Romania (Timis and Arad) from November 2017 to February 2019. We collected chronic electronic prescriptions issued for elderly patients (>65 years old) with chronic conditions. The medication was prescribed by generalist or specialist physicians for periods ranging between 30 and 90 days. To assess inappropriate prescribing behaviours, a multidisciplinary team of specialists applied the Screening Tool of Older Persons' Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) v.2 criteria to the collected prescriptions. : Within the 1498 prescriptions included in the study, 57% were issued to females, the mean age was 74.1 ± 6.95, and the average number of medicines per prescription was 4.7 ± 1.51. The STOPP criteria most commonly identified were the (1) long treatment duration (23.6%) and (2) prescription of neuroleptics (14.6%) or zopiclone (14.0%) as medications that increase the risk of falls. According to START criteria, the following medicines were under-prescribed: (1) statins (47.4%), (2) beta-blockers (24.5%), (3) antiresorptive therapy (10.0%), and (4) β2-agonists and muscarinic antagonists for chronic obstructive pulmonary disease (COPD) (4.5%). Within our study group, the prevalence of potentially inappropriate medications was 18.58%, whereas the prevalence of potential prescribing omissions was 49.2%. : To decrease medication-related harm and morbid-mortality, and to increase the quality of life for elderly people in Romania, immediate actions are needed from national authorities. These actions include reinforcing primary care services, providing periodic training for physicians, implementing medication review services by pharmacists, and utilising electronic health records at their full capacity.
包括罗马尼亚在内的许多欧洲国家都面临着人口快速老龄化的问题。此外,罗马尼亚的预期寿命在欧盟中处于最低水平。有鉴于此,为了确保并加强药物治疗和医疗行为,对药物相关危害的评估必须成为国家优先事项。在本研究中,我们试图描述和评估罗马尼亚老年人群中处方不足的情况。
我们于2017年11月至2019年2月在罗马尼亚西部两个县(蒂米什县和阿拉德县)的城市地区进行了一项横断面研究。我们收集了为患有慢性病的老年患者(>65岁)开具的慢性电子处方。这些药物由全科医生或专科医生开具,疗程为30至90天。为了评估不适当的处方行为,一个多学科专家团队将老年人处方筛查工具/正确治疗警报筛查工具(STOPP/START)第2版标准应用于所收集的处方。
在纳入研究的1498份处方中,57%是开给女性的,平均年龄为74.1±6.95岁,每份处方的平均药物数量为4.7±1.51种。最常被识别出的STOPP标准是:(1)治疗时间长(23.6%);(2)将抗精神病药物(14.6%)或佐匹克隆(14.0%)作为增加跌倒风险的药物进行处方。根据START标准,以下药物处方不足:(1)他汀类药物(47.4%);(2)β受体阻滞剂(24.5%);(3)抗吸收治疗药物(10.0%);(4)用于慢性阻塞性肺疾病(COPD)的β2激动剂和毒蕈碱拮抗剂(4.5%)。在我们的研究组中,潜在不适当用药的患病率为18.58%,而潜在处方遗漏的患病率为49.2%。
为了减少药物相关危害和病死情况,并提高罗马尼亚老年人的生活质量,国家当局需要立即采取行动。这些行动包括加强初级保健服务、为医生提供定期培训、由药剂师开展药物审查服务以及充分利用电子健康记录。